Bladder cancer: open trials in Brazil

11 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Fundacao Pio XII, Barretos · Universidade Estadual De Campinas, Campinas · Liga Norte Riograndense Contra o Cancer, Natal · Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Hospital Moinhos de Vento, Porto Alegre · HBA SA Assitencia Medica e Hospitalar, Salvador · CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo André · Irmandade Santa Casa de Misericordia de Sao Paulo, São Paulo · Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo, São Paulo · Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo · Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Liga Norte Riograndense Contra o Cancer, Natal · Hospital Regional do Cancer Hospital de Esperanca, Presidente Prudente · Funfarme Sjrp, São José do Rio Preto · Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo, São Paulo · Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
ICTRIALS Pesquisa e Desenvolvimento ( Site 0107), Curitiba · Hospital Moinhos de Vento ( Site 0102), Porto Alegre · Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0110), São José do Rio Preto · Hospital Alemao Oswaldo Cruz ( Site 0101), São Paulo
Registry updated 2026-11-03
NCT07008833
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
Trial Treatment · Brazilian Clinical Research Institute
Brazilian Clinical Research Institute, São Paulo
Registry updated 2026-10-29
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital de Cancer de Barretos - Fundacao Pio XII, Barretos · Cepon - Centro de Pesquisas Oncolă"Gicas de Santa Catarina, Florianópolis · Centro de Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho, Jaú · Hospital de Clinicas de Porto Alegre, Porto Alegre · Hospital Sao Lucas da PUCRS, Porto Alegre
Registry updated 2026-10-26
NCT06960577
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
Trial Treatment · Phase 2 · AstraZeneca
Barretos · Jaú · Natal · Porto Alegre · Rio de Janeiro · Santo André · São José do Rio Preto · São Paulo
Registry updated 2026-10-08
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos · CPAM - Centro de Pesquisas da Amazônia, Belém · Hospital Tacchini, Bento Gonçalves · IOP Pesquisa, Curitiba · Hospital de Cancer de Londrina, Londrina · Liga Norte Riograndense Contra o Cancer, Natal · Hospital Nossa Senhora da Conceição, Porto Alegre · Instituto de Oncologia Saint Gallen, Santa Cruz do Sul · Centro de Oncologia - CEON+ - Unidade São Caetano do Sul, São Caetano do Sul · Hospital BP, São Paulo · Hospital Alemão Oswaldo Cruz, São Paulo · Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo
Registry updated 2026-10-07
NCT06833073
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0400), Barretos · Instituto do Câncer e Transplante de Curitiba ( Site 0402), Curitiba · Hospital de Clínicas de Passo Fundo ( Site 0406), Passo Fundo · Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0410), São Jose Do Rio Preto
Registry updated 2026-10-01
NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Protara Therapeutics
Hospital de Clínicas da UNICAMP, Campinas · Instituto Dor de Pesquisa e Ensino, Jardim Paulista · Office of Lucas Nougeria MA, Nova Lima · Kyushu University Hospital, Nova Lima · Centro de Urologia Avancada, Porto Alegre · Santa Casa de Misericordia de Porto Alegre, Porto Alegre · Nucleo de Pesquisa Clinica do Rio Grande so Sul, Porto Alegre · Faculdade de Medicina ABC-CEPHO, Santo André
Registry updated 2026-08-24
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Porto Alegre · Rio de Janeiro · Salvador · São Paulo
Registry updated 2026-07-29
NCT07720284
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Trial Treatment · Phase 3 · AstraZeneca
Barretos · Curitiba · Salvador · São Paulo
Registry updated 2026-07-22

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error